![]() |
![]() |
(11) | Number of the document | |
(68) | Number of the document | 4176894 |
(21) | Application number for Supplementary Protection Certificate | PA 2024 536 |
(22) | Date of filing the application | 2024-12-13 |
(41) | Date of publication of the application | 2025-01-10 |
Date of publication of SPC | ||
(24) | Date of coming into effect of SPC |
(71) |
Bioverativ Therapeutics Inc. ,
225 Second Avenue, Waltham MA 02451,
US
|
(73) |
Bioverativ Therapeutics Inc. ,
225 Second Avenue, Waltham MA 02451,
US
|
(74) |
Vitalija BANAITIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
(93) | EU/1/24/1824, 2024-06-17 |
(95) | Efanesoktokogas alfa arba panašus biologinis medicinos produktas, apsaugotas pagrindiniu patentu |
SPC application published |